Embryo‐fetal developmental toxicity study design for pharmaceuticals
Birth Defects Research Part B: Developmental and Reproductive Toxicology · 2009-12 · 86 (6) · 418-428
DOI: 10.1002/bdrb.20214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Birth Defects Research Part B: Developmental and Reproductive Toxicology, online erschienen am 18.12.2009. Verfasst von L David Wise und 8 weiteren Autor:innen. Beteiligte Einrichtung: Merck Research Laboratories, West Point, Pennsylvania 19486, USA. ld_wise@merck.com. Hauptthemen laut MEDLINE: Abnormalities, Drug-Induced, Drug Evaluation, Preclinical, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Assessment of potential developmental and reproductive toxicity of human pharmaceuticals is currently guided by the International Conference on Harmonization (ICH) S5(R2) document (available at http://www.ich.org ). The studies that assess developmental hazard are generally conducted in rodents and rabbits. Based on the authors' collective experience, adequate designs (including range‐finding studies) and the presentation of data for these studies are described in detail. In addition, the suggested initiation and then total duration of these studies in relation to clinical studies that enroll women of childbearing potential are described. Optional parameters that may be included in the studies are discussed, as are study designs that combine assessments of fertility and developmental toxicity. New methods that may replace or enhance current procedures are outlined. The details described herein will assist all laboratories performing these studies, individuals who need to plan for the studies, and regulatory agencies that ultimately review these studies. Birth Defects Res (Part B) 86:418–428, 2009. © 2009 Wiley‐Liss, Inc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Merck Research Laboratories, West Point, Pennsylvania 19486, USA. ld_wise@merck.com
Zitieren
APA
Wise, L. D., Buschmann, J., Feuston, M. H., Fisher, J. E., Hew, K. W., Hoberman, A. M., Lerman, S. A., Ooshima, Y., & Stump, D. G. (2009). Embryo‐fetal developmental toxicity study design for pharmaceuticals. Birth Defects Research Part B: Developmental and Reproductive Toxicology, 86(6), 418-428. https://doi.org/10.1002/bdrb.20214
Vancouver
Wise LD, Buschmann J, Feuston MH, Fisher JE, Hew KW, Hoberman AM, et al. Embryo‐fetal developmental toxicity study design for pharmaceuticals. Birth Defects Research Part B: Developmental and Reproductive Toxicology. 2009;86(6):418-428. doi:10.1002/bdrb.20214
BibTeX
@article{Wise2009,
author = {Wise, L David and Buschmann, Jochen and Feuston, Maureen H and Fisher, J Edward and Hew, Kok Wah and Hoberman, Alan M and Lerman, Steven A and Ooshima, Yojiro and Stump, Donald G},
title = {Embryo‐fetal developmental toxicity study design for pharmaceuticals},
journal = {Birth Defects Research Part B: Developmental and Reproductive Toxicology},
year = {2009},
volume = {86},
number = {6},
pages = {418--428},
doi = {10.1002/bdrb.20214}
}
EUVIMED